Dystonia: Recent advances

Journal of Clinical Neuroscience

Volumn 6, Issue 1, 1999, Pages 1-8

  Thyagarajan, Dominic ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

Molecular genetics; Primary torsion dystonia; Secondary dystonia

Indexed keywords

EID: 0001769688     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0967-5868(99)90593-3     Document Type: Review

References (103)

1. Oppenheim H. Über eine eigenartige Krampfkrankeheit des kinlichen Alters (Dysbasia lordotica progressiva, Dystonia musculoram deformans). Neurol Centrabl 1911; 30: 1090-1107.
2. Zeman W. Dystonia: an overview. Adv Neurol 1976; 14: 91-103.
3. Fahn S, Marsden CD. Calne DB. Classification and investigation of dystonia. In: Marsden CD, Fahn S, Eds: Movement Disorders 2. London: Butterworths, 1987: 332-358.
4. Jankovic J, Fahn S. Physiologic and pathologic tremors. Diagnosis, mechanism and management. Ann Int Med 1980; 93: 460-465.
5. Yanagisawa N, Goto A. Dystonia musculorum deformans: Analysis with electromyography. J Neurol Sci 1971; 13: 39-65.
6. Koller WC, Busenbark K, Miner K, the Essential Tremor study group. The relationship of essential tremor to other movement disorders: report on 678 patients. Ann Neurol 1994; 35: 717-723.
7. Lou JS, Jankovic J. Essential tremor: clinical correlates in 350 patients. Neurology 1991; 41: 234-238.
8. Conway D, Bain PG, Warner TT et al. Linkage analysis with chromosome 9 markers in hereditary essential tremor. Mov Disord 1993; 8: 374-376.
9. Gulcher JR, Jonsson P, Kong A et al. Mapping of a familial essential tremor gene, FET1 to chromosome 3q13. Nature Genet 1997; 17: 84-87.
10. Fahn S, Hening WA, Bressman S, Burke R, Ilson J, Walters A. Long-term usefulness of baclofen in the treatment of essential blepharospasm. Adv Ophthal Plast Reconstr Surg 1985; 4: 219-226.
11. Fahn S. Clincal variants of idiopathic torsion dystonia. J Neurol Neurosurg Psychiatry 1989; Supplement: 96-100.
12. Green P, Kang UJ, Fahn S. Spread of symptoms in idiopathic torsion dystonia. Mov Disord 1995; 10: 143-152.
13. Fahn S. Generalised dystonia: concept and treatment. Clin Neuropharmacol 1986; 9 (Suppl 2): S37-S48.
14. Zeman W. Pathology of the torsion dystonias (dystonia muscluorum deformans). Neurology 1970; 20: 79-88.
15. Zweig RM, Hedreen JC, Jankel WR, Casanove MF, Whitehouse PJ, Price DL. Pathology in brainstem regions of individuals with primary dystonia. Neurology 1988; 38: 702-706.
16. Marsden CD. Obeso JA. Zarranz JJ, Lang AE. The anatomical basis of symptomatic hemidystonia. Brain 1985; 108: 463-483.
17. Lehericy S, Vidailhet M, Dormont D et al. Striatopallidal and thalamic dystonia: a magnetic resonance imaging anatomoclinical study. Arch Neurol 1996; 53: 241-250.
18. Jankovic J, Patel SC. Blepharospasm associated with brainstem lesions. Neurology 1983; 33: 1237-1240.
19. Schneider S, Feifel E, Ott D, Schumacher M, Lucking CH, Deuschl G. Prolonged MRIT2 times of the lentiform nucleus in idiopathic spasmodic torticollis. Neurology 1994; 44: 846-850.
20. Naumann M, Becker G, Toyka KV, Supprian T, Reiners K. Lenticular nucleus lesion in idiopathic dystonia detected by transcranial sonography. Neurology 1996; 47: 1284-1290.
21. Eidelberg D, Moeller JR, Ishikawa T et al. The metabolic topography of idiopathic torsion dystonia. Brain 1995; 118: 1473-1484.
22. Playford ED, Fletcher NA, Sawle GV, Marsden CD, Brooks DJ. Striatal [F-18] dopa uptake in familial idiopathic dystonia. Brain 1993; 116: 1191-1199.
23. Nutt JG, Muenter MD, Aronson A, Kurland LT, Melton LJ. Epidemiology of focal and generalized dystonia in Rochester, Minnesota. Mov Disord 1988; 3: 188-194.
24. Zilber N, Korczyn AD, Kahana E, Fried K, Alter M. Inheritance of idiopathic torsion dystonia among Jews. J Med Genet 1984; 21: 13-20.
25. Risch N, De Leon D, Ozelius L et al. Genetic analysis of idiopathic torsion dystonia in Ashkenazi Jews and their recent descent from a small founder population. Nat Genet 1995; 9: 152-159.
26. Bressman SB, De Leon D, Kramer PL et al. Dystonia in Ashkenazi Jews: clinical characterisation of a founder mutation. Ann Neurol 1994; 36: 771-777.
27. Ozelius LJ, Kramer PL, de Leon D et al. Strong allelic association between the torsion dystonia gene (DYT1) and loci on chromosome 9q34 in Ashkenazi Jews. Am J Hum Genet 1992; 50: 619-628.
28. De Leon D, Brin MF, Murphy P et al. Genetic counselling for idiopathic torsion dystonia: first use of DNA based carrier detection in Ashkenazic Jews. Mov Disord 1991; 6: 273-274.
29. Marsden CD, Harrison MJG. Idiopathic torsion dystonia: a review of 42 patients. Brain 1974; 97: 793-810.
30. Fahn S. The varied clinical expressions of dystonia. Neurol Clin 1984; 2: 541-554.
31. Burke RE, Brin MF, Fahn S, Bressman SB, Moskowitz C. Analysis of the clinical course of non-Jewish autosomal dominant torsion dystonia. Mov Disord 1986: 1: 163-178.
32. Fletcher NA, Harding AE, Marsden CD. A genetic study of idiopathic torsion dystonia in the UK. Brain 1990; 113: 375-395.
33. Ozelius L, Kramer PL, Moskowitz CB et al. Human gene for torsion dystonia located on chromosome 9q32-34. Neuron 1989; 2: 1427-1434.
34. Kramer PL, Ozelius L, De Leon D et al. Dystonia gene in Ashkenazi Jewish population located on chromosome 9q32-34. Ann Neurol 1990; 27: 114-120.
35. Kramer PL, Heiman GA, Gasser T et al. The DYT1 gene on 9q34 is responsible for most cases of early limb-onset idiopathic torsion dystonia in non-Jews. Am J Hum Genet 1994; 55: 468-475.
36. Bressman SB, De Leon D, Brin MF et al. Idiopathic torsion dystonia among Ashkenazi Jews: evidence for autosomal dominant inheritance. Ann Neurol 1989; 26: 612-620.
37. Risch N, De Leon D, Bressman et al. Segregation analysis of idiopathic torsion dystonia in Ashkenazi Jews suggests autosomal dominant inheritance. Am J Hum Genet 1990; 46: 533-438.
38. Elridge T, Ryan E, Brody J, Cooper I. Dystonia musculorum deformans: evidence for two hereditary forms. In: Barbeau A, Brunette JN (eds). Prog Neurogenet. Amsterdam: Excerpta Medica, 1969: 772-788.
39. Pauls DL, Korczyn AD. Complex segregation analysis of dystonia pedigrees suggests autosomal dominant inheritance. Neurology 1990; 40: 1107-1110.
40. Gimenez-Roldan S, Lopez-Fraile IP, Esteban A. Dystonia in Spain: study of a Gypsy family and general survey. Adv Neurol 1976 14: 125-136.
41. Bressman SB, Heiman GA, Nygaard TG et al. A study of idiopathic torsion dystonia in a non-Jewish family: evidence for genetic heterogeneity. Neurology 1994; 44: 283-287.
42. Bressman SB, Hunt AL, Heiman GA et al. Exclusion of the DYT1 locus in a non-Jewish family with early onset-onset dystonia. Mov Disord 1994; 9: 626-632.
43. Holmgren G, Ozelius L, Forsgren L et al. Adult onset idiopathic torsion dystonia is excluded from the DYT1 region (9q34) in a Swedish family. J Neurol Neurosurg Psychiatry 1995; 59: 178-179.
44. Bressman SB, Warner TT, Almasy L et al. Exclusion of the DYT1 locus in familial torticollis. Ann Neurol 1996; 40: 681-684.
45. Ozelius LJ, Hewett JW, Page CE et al. The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein. Nature Genet 1997; 17: 40-48.
46. Leube B, Rudnicki D, Ratzlaff T, Kessler KR, Benecke R, Auburger G. Idiopathic torsion dystonia: assignment of a gene to chromosome 18p in a German family with adult onset, autosomal dominant inheritance and purely focal distribution. Hum Mol Genet 1996; 10: 1673-1677.
47. Kakinuma S, Sasabe F, Negoro K, Nogaki H, Morimatsu M. 18p syndrome with bilateral pyramidal signs, dystonia of the lower extremities and concentric visual defects. Clin Neurol 1994; 34: 474-478.
48. Carstea ED, Polymeropoulos MH, Parker CC et al. Linkage of Nieman-Pick type C to human chromosome 18. Proc Natl Acad Sci USA 1993; 90: 2002-2004.
49. Uitti RJ, Maraganore DM. Adult-onset familial cervical dystonia: report of a family including monozygotic twins. Mov Disord 1993; 8: 489-494.
50. Thompson JH. A wry-necked family. Lancet 1896; 2: 24.
51. Waddy HM, Fletcher NA, Harding AE, Marsden CD. A genetic study of idiopathic focal dystonias. Ann Neurol 1991; 29: 320-324.
52. Ahmad F, Davis MB, Waddy HM, Oley CA, Marsden CD, Harding AE. Evidence for locus heterogeneity in autosomal dominant torsion dystonia. Genomics 1993; 15: 9-12.
53. Parker N. Hereditary whispering dystonia. Journal Neurol Neurosurg Psychiatry 1985; 48: 218-224.
54. Almasy L, Bressman SB, Raymond D et al. Idiopathic torsion dystonia linked to chromosome 8 in two Mennonite families. Ann Neurol 1997; 42: 670-673.
55. Grandas F, Elston J, Quinn N, Marsden CD. Blepharospasm : a review of 264 patients. J Neurol Neurosurg Psychiatry 1988; 51; 767-772.
56. Friedman A, Fahn S. Spontaneous remission in spasmodic torticollis. Neurology 1986; 36: 398-400.
57. Jankovic J, Leder S, Warner D, Schwartz K. Cervical dystonia: clinical findings and associated movement disorders. Neurology 1991; 41: 1088-1091.
58. Tolosa ES. Clinical features of Meige's disease: idiopathic orofacial dystonia. Arch Neurol 1981; 38: 147-152.
59. Ayd FJ. A survey of drug-induced extrapyramidal reactions. JAMA 1961; 175: 1054-1060.
60. Aguilar EJ, Keshavan MS, Martinez-Quiles MD, Hernandez J, Gomez-Beneyto M, Schooler NR. Predictors of acute dystonia in first-episode psychotic patients. Am J Psychiatry 1994; 151: 1819-1821.
61. Garver DL, Davis JM, Dekermejian H, Erickson S, Gosenfeld L, Haraszti J. Dystonic reactions following neuroleptics: time course and proposed mechanism. Psychopharmacologica 1976; 47: 199-201
62. Marsden CD, Jenner P. The pathophysiology of exttapyramidal side-effects of neuroleptic drugs. Psychol Med 1980; 10: 55-72.
63. Ornadel D, Barnes EA, Dick DJ. Acute dystonia due to amitriptyline. J Neurol Neurosurg Psychiatry 1992; 55: 414.
64. Graudins A, Fern RP. Acute dystonia in a child associated with therapeutic ingestion of a dextromethorphan containing cough and cold syrup. J Toxicol-Clin Toxicol 1996; 34: 351-352.
65. Friedman JH, Kucharski LD, Wagner RL. Tardive dystonia in a psychiatric hospital. J Neurol Neurosurg Psychiatry 1986; 50: 801-803.
66. Sethi KD, Hess DC, Harp RJ. Prevalence of dystonia in veterans on chronic antipsychotic therapy. Mov Disord 1990; 5: 319-321.
67. Kang UJ, Burke RE, Fahn S. Natural history and treatment of tardive dystonia. Mov Disord 1986; 1: 193-208.
68. Kyllerman M, Skjeldal OH, Lundberg MA-H et al. Dystonia and dyskinesia in glutaric aciduria type I: clinical heterogeneity and therapeutic considerations. Mov Disord 1994; 9: 22-30.
69. DiMauro S, De Vivo DC. Genetic heterogeneity in Leigh syndrome. Ann Neurol 1996 Jul; 40: 5-7.
70. Tatuch Y, Christodoulou J, Feigenbaum et al. Heteroplasmic mtDNA mutation (T->G) at 8993 can cause Leigh disease when the percentage of abnormal mtDNA is high. Am J Hum Genet 1992; 50: 852-858.
71. Thyagarajan D, Shanske S, Vazquez-Memije M, DeVivo DC, DiMauro S. A novel ATPase 6 point mutation in familial bilateral striatal necrosis. Ann Neurol 1995; 38: 468-472.
72. Jun AS, Brown MD, Wallace DC. A mitochondrial DNA mutation at nucleotide pair 14459 of the NADH dehydrogenase subunit 6 gene associated with maternally inherited Leber hereditary optic neuropathy and dystonia. Proc Natl Acad Sci USA 1994; 91: 6206-6210.
73. De Vries DD, Went LN, Bruyn GW et al. Genetic and biochemical impairment of mitochondrial Complex I activity in a family with Leber Hereditary Optic Atrophy and hereditary spastic dystonia. Am J Hum Genet 1996; 58: 703-711.
74. He FS, Zhang SL, Qian FY, Zhang CL. Delayed dystonia with striatal lucencies induced by a mycotoxin (3-nitroproprionic acid). Neurology 1995; 45: 2178-2183.
75. Valenzuela R, Court J, GodoyJ. Delayed cyanide induced dystonia. J Neurol Neurosurg Psychiatry 1992; 55: 198-199
76. Saint-Hilaire MH, Burke RE, Bressman SB, Brin MN, Fahn S. Delayed-onset dystonia due to perinatal or early-childhood dystonia. Neurology 1991; 41: 216-222.
77. Scott BL, Jankovic J. Delayed -onset progressive movement disorders after static brain lesions. Neurology 1996; 46: 68-74.
78. Maraganore DM, Folger WN, Swanson JW, Ahlskog JE. Movement disorders as sequelae of central pontine myelinolysis: report of 3 cases. Mov Disord 1992; 7: 142-148.
79. Lee MS, Rinne JO, Ceballos-Baumann A, Thompson PD, Marsden CD. Dystonia after head trauma. Neurology 1994; 44: 1374-1378.
80. Fahn S, Elridge R. Definition and classification of the dystonic states. Adv Neurol 1976; 14: 1-5.
81. Fahn S, Williams DT. Psychogenic dystonia. Adv Neurol 1988; 50: 431-455.
82. Segawa M, Hosaka A, Miyagawa F, Nomura Y, Imai H. Hereditary progressive dystonia with marked diurnal fluctuation. Adv Neurol 1976; 14: 215-233.
83. Nygaard TG, Takahashi H, Heiman GA, Snow BJ, Fahn S, Calne DB. Long-term treatment response and fluorodopa positron emission tomographic scanning of parkinsonism in a family with dopa-responsive dystonia. Ann Neurol 1992; 32: 603-608.
84. Harwood G, Heirons R, Fletcher NA, Marsden CD. Lessons from a remarkable family with DOPA-responsive dystonia. J Neurol Neurosurg Psychiatry 1994; 45: 2178-2183.
85. Nygaard TG, Wilhelmsen KC, Risch NJ et al. Linkage mapping of doparesponsive dystonia (DRD) to chromosome 14q. Nature Genetics 1993; 5: 386-391.
86. Ichinose H, Ohye T, Takahashi E et al. Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nat Genet 19948: 236-242.
87. Hirano M, Tamaru Y, Nagai Y, Ito H, Imai T, Ueno S. Exon skipping caused by a base substitution at a splice site in the GTP cyclohydrolase I gene in a Japanese family with hereditary progressive dystonia/dopa responsive dystonia. Biochem Biophys Res Comm 1995; 213: 645-651.
88. Hirano M, Tamaru Y, Ito H, Matsumoto S, Imai T, Ueno S. Mutant GTP cyclohydrolase I mRNA levels contribute to Dopa-responsive dystonia onset. Ann Neurol 1996; 40: 796-798.
89. Rajput AH, Gibb WRG, Zhong XH et al. DOPA-responsive dystoniapathological and biochemical observations in a case. Ann Neurol 1994; 35: 396-402.
90. Ludecke B, Dworniczak B, Bartholomew K. A point mutation in the tyrosine hydroxylase gene associated with Segawa's syndrome. Hum Genet 1995; 95: 123-125.
91. Knappskog PM, Glatmark T, Mallet J, Ludecke B, Bartholomew K. Recessively inherited L-dopa-responsive dystonia caused by a point mutation (Q381K) in the tyrosine hydroxylase gene. Hum Mol Genet 1995; 4: 1209-1212.
92. Hyland K, Fryburg JS, Wilson WG et al. Oral phenylalanine loading in doparesponsive dystonia: a possible diagnostic test. Neurology 1997; 48: 1290-1297.
93. Obeso JA, Rothwell JC, Lang AE, Marsden CD. Myoclonic dystonia. Neurology 1983; 33: 825-830.
94. Quinn NP, Rothwell JC, Thompson PD, Marsden CD. Hereditary myoclonic dystonia, hereditary torsion dystonia, essential myoclonus: an area of confusion. Adv Neural 1988; 50: 391-401.
95. Fahn S, Sjaastad O. Hereditary essential myoclonus in a large Norwegian family. Mov Disord 1991; 6: 237-247.
96. Dobyns WB, Ozelius LJ, Kramer PL et al. Rapid-onset dytonia-Parkinsonism. Neurology 1993; 43: 2596-2602.
97. Brashear A, DeLeon D, Bressman S, Thyagarajan D, Farlow MR, Dobyns WB. Rapid-onset dystonia-parkinsonism in a second family. Neurology 1997; 48: 1066-1069.
98. Lee LV, Pascasio FM, Fuentes FD, Viterbo GH. Torsion dystonia in Panay, Phillipines. Adv Neurol 1976; 14: 137-151.
99. Waters CH, Takahashi H, Wilhelmsen et al. Phenotypic expression of X-linked dystonia-parkinsonism (lubag) in two women. Neurology 1993; 43 1555-1558.
100. Haberhausen G, Schmitt I, Kohler A et al. Assignment of the dystoniaparkinsonism syndrome locus, DYT3, to a small region within a 1.8 Mb YAC contig of Xq13.1. Am J Hum Genet 1995; 57: 644-650.
101. Wilhelmsen KC, Weeks DE, Nygaard TG et al. Genetic mapping of "lubag" (X-linked dystonia-parkinsonism) in a Filipino kindred to the pericentromeric region of the X chromosome. Ann Neurol 1991; 29: 124-131.
102. Waters CH, Faust PL, Powers J, et al. Neuropathology of Lubag (X-linked dystonia-parkinsonism). Mov Disord 1993; 8: 387-390.
103. Gibb WRG, Kilford L, Marsden CD. Severe generalised dystonia with a mosaic pattern of striatal gliosis. Mov Disord 1992; 7: 217-223.